phase ii and iii studies of cnm-au8 in als
Published 3 years ago • 207 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:51
phase ii extension trial of cnm-au8 in als
-
3:11
cnm-au8 gold nanocatalysts to slow disease progression in als
-
1:16
results of clinical trials for cnm-au8, a potential als treatment
-
3:30
repair-ms: 31p-mrs imaging to assess the effects of cnm-au8 in ms
-
1:43
can gold-based nanotechnology meet the need for neuro-reparative therapies in ms?
-
1:44
unanswered questions in als research
-
1:49
the pipeline of late-stage therapeutic options for patients with als
-
1:07
synapse loss and cognitive decline in als: a common feature with alzheimer’s?
-
4:51
visionary-ms: pure gold nanocrystals for neurorepair and neuroprotection in ms
-
5:19
clinical trials for als
-
1:48
personalizing therapy: the future of als treatment
-
6:10
phase 2 clinical trial update 1
-
55:45
phase ii clinical trials
-
11:05
ac22 - clonal origins of metastatic cholangiocarcinoma
-
3:03
pridopidine application beyond huntington’s disease
-
46:57
case studies of phase 2 adaptive dose-finding trials - jim bolognese
-
2:38
primary and secondary resistance in aml
-
1:03
dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc
-
1:04
ascend-2 and ascend-3 trials: ceritinib in alk-rearranged nsclc with brain metastases